The widespread use of colchicine may expose a large population to potential risk, especially patients with impaired renal function undergoing combination drug therapies that share common metabolic pathways.

Clinicians should be cautious when co-administering colchicine with other drugs, especially in patients with impaired renal function.

Serious neuromuscular adverse events could occur with the concurrent use of colchicine and fluconazole.